NovoCure Limited
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $562.2M | $410.5M | $208.8M |
| FY2022 | $565.5M | $441.2M | $115.3M |
| FY2023 | $568.8M | $362.5M | $240.8M |
| FY2024 | $97.3M | $360.2M | $163.8M |
| FY2025 | $195.0M | $340.5M | $93.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $562.2M | $410.5M | $208.8M |
| FY2022 | $565.5M | $441.2M | $115.3M |
| FY2023 | $568.8M | $362.5M | $240.8M |
| FY2024 | $97.3M | $360.2M | $163.8M |
| FY2025 | $195.0M | $340.5M | $93.5M |